Reuters logo
Belgium cuts Glaxo H1N1 vaccine order by a third
January 15, 2010 / 9:12 AM / 8 years ago

Belgium cuts Glaxo H1N1 vaccine order by a third

BRUSSELS, Jan 15 (Reuters) - Belgium has cut its order for GlaxoSmithKline’s (GSK.L) swine flu vaccine Pandemrix by a third, the latest country to cancel part of its supply due to lower than expected demand.

The Belgian health ministry said on Friday the reduction in the H1N1 order presented a saving of about 33 million euros ($47.6 million). It had initially ordered 12.6 million doses of the vaccine.

For an analysis on Glaxo flu orders, click [ID:nLDE60D0C4] ($1=.6931 euros) (Reporting by Ben Deighton and Ben Hirschler; Editing by Mike Nesbit)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below